Physician profile
Thomas Lozowski
NPI 1104897354
$39,961.85
in general payments reported to CMS, 2019-2025
92 companies · $6,084 in 2025
The $6,084 reported for 2025 was more than what 99% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,828 · 2020: $3,941 · 2021: $6,613 · 2022: $5,786 · 2023: $6,719 · 2024: $6,991 · 2025: $6,084.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $19K · Education: $308.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $19,486.58 |
| Education | $307.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $7,830.68 | 2019-2025 | Fasenra, Farxiga, Tezspire |
| Abbvie INC. | $3,198.67 | 2021-2025 | |
| Glaxosmithkline, LLC. | $2,100.95 | 2019-2025 | Trelegy Ellipta, Nucala, Shingrix |
| Abbott Laboratories | $1,685.35 | 2019-2025 | Freestyle Libre 3 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,545.56 | 2019-2025 | Xifaxan, Trulance |
| Pfizer INC. | $1,468.06 | 2019-2025 | |
| Lilly USA, LLC | $1,260.29 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $1,091.45 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Bayer Healthcare Pharmaceuticals INC. | $1,073.37 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $898.84 | 2021-2025 | Dupixent |
| Takeda Pharmaceuticals U.S.A., INC. | $891.12 | 2019-2025 | Trintellix |
| Amgen INC. | $832.96 | 2019-2025 | Repatha, Otezla, Otezla |
| Merck Sharp & Dohme LLC | $797.68 | 2019-2025 | Verquvo, Belsomra, Steglatro |
| Kowa Pharmaceuticals America, INC. | $757.82 | 2019-2025 | Zoryve, Seglentis, Livalo |
| Esperion Therapeutics, INC. | $680.62 | 2020-2025 | Nexletol |
Show all 92 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mannkind Corporation | $676.99 | 2019-2025 | Afrezza |
| Allergan, INC. | $646.99 | 2019-2020 | |
| Mylan Specialty L.P. | $637.13 | 2019-2024 | Yupelri |
| Sunovion Pharmaceuticals INC. | $629.03 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $621.92 | 2019-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $581.74 | 2020-2025 | Jardiance |
| Corcept Therapeutics | $560.15 | 2023-2025 | Korlym |
| Philips North America LLC | $538.44 | 2020-2025 | (Ak6) Vest Therapy, Vest Therapy Und, (8874) Incourage |
| Sanofi-Aventis U.S. LLC | $507.97 | 2019-2024 | |
| Antares Pharma, INC. | $466.70 | 2020-2025 | Xyosted |
| Axsome Therapeutics, INC. | $441.62 | 2022-2025 | Sunosi, Auvelity, Symbravo |
| Teva Pharmaceuticals USA, INC. | $426.17 | 2019-2025 | Austedo Xr, Austedo, Austedo Xr |
| Astellas Pharma US INC | $419.90 | 2019-2025 | Veozah, Myrbetriq |
| Scilex Pharmaceuticals INC. | $411.37 | 2019-2025 | Ztlido |
| Currax Pharmaceuticals LLC | $333.58 | 2019-2025 | Contrave, Onzetra Xsail, Nexlizet |
| Genzyme Corporation | $307.06 | 2023-2025 | |
| Phathom Pharmaceuticals, INC. | $305.31 | 2024-2025 | Voquezna |
| Amarin Pharma, INC. | $285.56 | 2019-2022 | |
| Otsuka America Pharmaceutical, INC. | $278.94 | 2022-2025 | Rexulti |
| Paratek Pharmaceuticals, INC. | $270.29 | 2021-2025 | Nuzyra, Xhance |
| Biohaven Pharmaceutical Holding Company LTD. | $227.06 | 2022 | |
| Supernus Pharmaceuticals, INC. | $219.32 | 2022-2023 | Qelbree, Xyosted |
| Eisai INC. | $218.94 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $210.71 | 2023-2025 | Gemtesa |
| Nestle Healthcare Nutrition INC. | $189.47 | 2021-2023 | |
| Horizon Therapeutics Plc | $184.26 | 2019-2023 | Krystexxa |
| Arbor Pharmaceuticals, INC. | $178.21 | 2019-2022 | |
| Biohaven Pharmaceuticals, INC. | $177.50 | 2020-2021 | |
| Exact Sciences Corporation | $171.92 | 2023-2025 | Cologuard Collection Kit |
| Tris Pharma INC | $153.49 | 2023-2025 | Dyanavel Xr |
| Dexcom, INC. | $151.38 | 2021-2025 | Dexcom G6 Transmitter |
| Tolmar, INC. | $135.77 | 2023-2025 | Jatenzo |
| Baxter Healthcare | $133.91 | 2025 | |
| Aimmune Therapeutics, INC. | $129.57 | 2024-2025 | Zenpep |
| Jazz Pharmaceuticals INC. | $114.44 | 2019-2022 | |
| Alk-Abello, INC | $102.92 | 2019-2022 | |
| Fidia Pharma USA INC. | $98.46 | 2019-2023 | Hymovis, Triluron, Hyalgan |
| Almatica Pharma LLC | $96.55 | 2023-2024 | Teriparatide, Loreev Xr, Gralise |
| Daiichi Sankyo INC. | $91.54 | 2022-2023 | Injectafer |
| Intra-Sana Laboratories | $85.09 | 2023-2024 | Reltone 400 Mg, Glycate, Reltone 200 Mg |
| Genentech USA, INC. | $83.90 | 2019-2021 | |
| Corium, LLC | $82.53 | 2023-2025 | Azstarys |
| Boston Scientific Corporation | $80.28 | 2019-2025 | Watchman Flx |
| Avanir Pharmaceuticals, INC. | $72.44 | 2019-2021 | |
| Si-Bone, INC. | $72.41 | 2019-2024 | |
| Topcon Healthcare Solutions, INC. | $66.43 | 2020 | |
| Verity Pharmaceuticals INC. | $63.44 | 2024-2025 | Trelstar, Tlando |
| Aytu Biopharma, INC. | $61.59 | 2019-2020 | |
| Xeris Pharmaceuticals, INC. | $61.48 | 2022-2025 | Recorlev, Gvoke Hypopen |
| Halozyme INC | $58.41 | 2023 | |
| Soleno Therapeutics, INC. | $56.97 | 2025 | Vykat Xr |
| Biodelivery Sciences International, INC. | $55.94 | 2021 | |
| Ibsa Pharma INC. | $54.07 | 2025 | Tirosint, Licart, Flector |
| Ironwood Pharmaceuticals, INC | $52.28 | 2019-2020 | |
| Lundbeck LLC | $50.89 | 2024-2025 | Rexulti |
| Nalpropion Pharmaceuticals LLC | $39.41 | 2019 | |
| Vanda Pharmaceuticals INC. | $35.24 | 2025 | Fanapt |
| Electromed, INC. | $33.97 | 2024 | Smartvest |
| Idorsia Pharmaceuticals US INC | $31.42 | 2023 | Quviviq |
| Vivus LLC | $28.37 | 2019-2020 | |
| Melinta Therapeutics, LLC | $28.06 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $23.22 | 2020-2021 | |
| Radius Health, INC. | $22.50 | 2020 | |
| Medicomp INC | $18.57 | 2024 | Telepatch Cardiac Monitor |
| Depuy Synthes Sales INC. | $18.37 | 2020 | |
| Viatris Specialty LLC | $17.97 | 2025 | Yupelri |
| Bioventus LLC | $17.63 | 2022 | |
| Medtronic, INC. | $17.47 | 2025 | Closurefast |
| Bausch Health US, LLC | $16.11 | 2022 | |
| Hikma Pharmaceuticals USA | $14.98 | 2019 | |
| Shionogi INC | $14.70 | 2019 | |
| Azurity Pharmaceuticals, INC. | $14.48 | 2023 | Edarbi |
| Pacira Pharmaceuticals Incorporated | $14.30 | 2024 | Exparel, Zilretta, Iovera |
| Neurelis, INC. | $14.08 | 2021 | |
| Watermark Medical, INC. | $13.61 | 2025 | |
| Ucb, INC. | $12.36 | 2022 | |
| Acorda Therapeutics, INC | $11.18 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Lozowski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.